Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
6.82
+0.39 (6.07%)
May 12, 2025, 4:00 PM - Market closed

Anbio Biotechnology Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
11.769.697.14.18
Short-Term Investments
--1.57-
Cash & Short-Term Investments
11.769.698.674.18
Cash Growth
21.40%11.75%107.33%-
Receivables
1.061.88-0.72
Inventory
--0.35-
Prepaid Expenses
5.714.174.920.02
Other Current Assets
0000
Total Current Assets
18.5315.7513.944.92
Property, Plant & Equipment
--0.01-
Long-Term Deferred Charges
0.390.04--
Other Long-Term Assets
-0.020-
Total Assets
18.9215.8113.964.92
Accounts Payable
1.630.831.411.89
Accrued Expenses
-0.13--
Other Current Liabilities
0.10.0300.49
Total Current Liabilities
1.730.991.412.38
Total Liabilities
1.730.991.412.38
Common Stock
0.010.01--
Additional Paid-In Capital
00--
Retained Earnings
17.1714.812.552.54
Shareholders' Equity
17.1914.8212.552.54
Total Liabilities & Equity
18.9215.8113.964.92
Net Cash (Debt)
11.769.698.674.18
Net Cash Growth
21.40%11.75%107.33%-
Net Cash Per Share
0.280.45--
Filing Date Shares Outstanding
43.8942.29--
Total Common Shares Outstanding
42.2942.29--
Working Capital
16.814.7612.532.54
Book Value Per Share
0.410.35--
Tangible Book Value
17.1914.8212.552.54
Tangible Book Value Per Share
0.410.35--
Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q